The Use of Statins in Respiratory Diseases

Author(s): Abbas Alshami, Mohammed Alazzawi, Joseph Varon

Journal Name: Current Respiratory Medicine Reviews

Volume 15 , Issue 1 , 2019

Become EABM
Become Reviewer

[1]
Jackevicius CA, Chou MM, Ross JS, Shah ND, Krumholz HM. Generic atorvastatin and health care costs. N Engl J Med 2012; 366(3): 201-4.
[2]
Todd PA, Goa KL. Simvastatin. A review of its pharmacological properties and therapeutic potential in hypercholesterolaemia. Drugs 1990; 40(4): 583-607.
[3]
Scandinavian simvastatin survival study group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344(8934): 1383-9.
[4]
MAAS Investigators. Effect of simvastatin on coronary atheroma: The Multicentre Anti-Atheroma Study (MAAS). Lancet 1994; 344(8923): 633-8.
[5]
Shishehbor MH, Brennan M-L, Aviles RJ, et al. Statins promote potent systemic antioxidant effects through specific inflammatory pathways. Circulation 2003; 108(4): 426-31.
[6]
Horn MP, Knecht SM, Rushing FL, et al. Simvastatin inhibits Staphylococcus aureus host cell invasion through modulation of isoprenoid intermediates. J Pharmacol Exp Ther 2008; 326(1): 135-43.
[7]
Graña L, Gathe Jr JC, Varon J. The role of statins in the Intensive Care Unit. Curr Respir Med Rev 2012; 8(1): 1.
[8]
Lee C-C, Lee M-TG, Hsu T-C, et al. A population-nased cohort study on the drug-specific effect of statins on sepsis outcome. Chest 2018; 153(4): 805-15.
[9]
Young RP, Hopkins R, Eaton TE. Pharmacological actions of statins: Potential utility in COPD. Eur Respir Rev 2009; 18(114): 222-32.
[10]
Wang M-T, Lo Y-W, Tsai C-L, et al. Statin use and risk of COPD exacerbation requiring hospitalization. Am J Med 2013; 126(7): 598-606.e2.
[11]
Lawes CMM, Thornley S, Young R, et al. Statin use in COPD patients is associated with a reduction in mortality: A national cohort study. Prim Care Respir J 2012; 21(1): 35-40.
[12]
Chung S-D, Tsai M-C, Lin H-C, Kang J-H. Statin use and clinical outcomes among pneumonia patients. Clin Microbiol Infect 2014; 20(9): 879-85.
[13]
Brassard P, Wu JW, Ernst P, Dell’Aniello S, Smiechowski B, Suissa S. The effect of statins on influenza-like illness morbidity and mortality. Pharmacoepidemiol Drug Saf 2017; 26(1): 63-70.
[14]
Black S, Nicolay U, Del Giudice G, Rappuoli R. Influence of statins on influenza vaccine response in elderly individuals. J Infect Dis 2016; 213(8): 1224-8.
[15]
Lai C-C, Lee M-TG, Lee S-H, et al. Statin treatment is associated with a decreased risk of active tuberculosis: An analysis of a nationally representative cohort. Thorax 2016; 71(7): 646-51.
[16]
O’Shea JJ, Pesu M, Borie DC, Changelian PS. A new modality for immunosuppression: Targeting the JAK/STAT pathway. Nat Rev Drug Discov 2004; 3(7): 555-64.


promotion: free to download

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 15
ISSUE: 1
Year: 2019
Page: [2 - 3]
Pages: 2
DOI: 10.2174/1573398X1501190709103017

Article Metrics

PDF: 15
HTML: 2
EPUB: 1
PRC: 1